vancomycin has been researched along with Pulmonary Consumption in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bifani, P; Daffé, M; De Bruyn, J; Fontaine, V; Lanéelle, MA; Laval, F; Lefèvre, P; Lemassu, A; Rens, C; Soetaert, K; Wang, XM | 1 |
| Masroor, MI; Redinger, RN | 1 |
| Pankey, GA | 1 |
4 other study(ies) available for vancomycin and Pulmonary Consumption
| Article | Year |
|---|---|
Increased Vancomycin Susceptibility in Mycobacteria: a New Approach To Identify Synergistic Activity against Multidrug-Resistant Mycobacteria.
Topics: Antitubercular Agents; Cell Wall; Drug Resistance, Multiple, Bacterial; Glycopeptides; Humans; Lipids; Microbial Sensitivity Tests; Mycobacterium bovis; Mycobacterium tuberculosis; Tuberculosis, Pulmonary; Vancomycin | 2015 |
A guide to TB, VRE, and MRSA.
Topics: Anti-Bacterial Agents; Centers for Disease Control and Prevention, U.S.; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Infection Control; Methicillin Resistance; Staphylococcal Infections; Tuberculosis, Pulmonary; United States; Vancomycin | 1998 |
Protean manifestations of tuberculosis in Kentucky: a case report and discussion.
Topics: Adult; Anti-Bacterial Agents; Diagnosis, Differential; Endocarditis, Bacterial; Humans; Kentucky; Male; Staphylococcal Infections; Tuberculosis, Pulmonary; Tuberculosis, Spinal; Vancomycin | 2001 |
Antibiotic therapy of infections of the lower respiratory tract.
Topics: Aerosols; Anti-Bacterial Agents; Cephalothin; Doxycycline; Erythromycin; Gentamicins; Humans; Lung Abscess; Lung Diseases, Fungal; Methicillin; Penicillin G; Penicillin V; Pneumonia; Polymyxins; Respiratory Tract Infections; Tuberculosis, Pulmonary; Vancomycin | 1971 |